Infectious Disease Research Institute (IDRI)
1124 Columbia Street
Suite 400
Seattle
Washington
98104
United States
Tel: 206-381-0883
Fax: 206-381-3678
Website: http://www.idri.org/
Email: office@idri.org
58 articles about Infectious Disease Research Institute (IDRI)
-
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine
4/18/2013
-
Infectious Disease Research Institute (IDRI) and Medicago, Inc. to Present Data at the World Vaccine Congress
4/9/2013
-
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1 Vaccine With GLA Adjuvant
8/16/2012
-
Infectious Disease Research Institute (IDRI) Expands Board, Adding Additional International Expertise With Dr Massimo Radaelli
7/3/2012
-
Soligenix Announces Collaboration with Infectious Disease Research Institute (IDRI) to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants
6/27/2012
-
Infectious Disease Research Institute (IDRI) Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters
5/31/2012
-
Aeras Global TB Vaccine Foundation and Infectious Disease Research Institute (IDRI) Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine
5/10/2012
-
Infectious Disease Research Institute (IDRI) Quest for Leprosy Vaccine Closer to Reality With Help of Million Dollar Grant
3/8/2012
-
Infectious Disease Research Institute (IDRI) Release: First Vaccine Against Fatal Visceral Leishmaniasis Enters Clinical Trial
2/23/2012
-
Infectious Disease Research Institute (IDRI) Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial
2/1/2012
-
Infectious Disease Research Institute (IDRI) Awarded Additional Funds for Novel TB Drugs
1/12/2012
-
Infectious Disease Research Institute (IDRI) Release: Human Trials Initiated for New HIV Vaccine
12/22/2011
-
Infectious Disease Research Institute (IDRI) Announces New VP Tuberculosis Drug Development
12/8/2011
-
Infectious Disease Research Institute (IDRI) to Present at India - U.S. Forum
11/30/2011
-
Eli Lilly and Company Provides Additional Funding to Infectious Disease Research Institute (IDRI) to Identify New Tuberculosis Therapies
11/17/2011
-
Infectious Disease Research Institute (IDRI) Partners With Global Research Initiative ADITEC to Accelerate Human Vaccine Development
10/17/2011
-
GlaxoSmithKline Donates Scientific Equipment to Advance Infectious Disease Research Institute (IDRI)'s Global Health Mission
10/4/2011
-
Infectious Disease Research Institute (IDRI) Launches New and Improved Website
9/7/2011
-
Infectious Disease Research Institute (IDRI), USAID Strike New Collaboration for Malaria Vaccine Development
8/16/2011
-
Infectious Disease Research Institute (IDRI) Announces New EVP Business Development & External Affairs: Erik Iverson to Join Infectious Disease Research Institute (IDRI) from Bill & Melinda Gates Foundation
8/4/2011